| Literature DB >> 28973146 |
Yelena Petrosyan1, Yeva Sahakyan2,3, Jan M Barnsley1, Kerry Kuluski1,4, Barbara Liu5, Walter P Wodchis1,6,7.
Abstract
Background: Despite the high prevalence of osteoarthritis and the prominence of primary care in managing this condition, there is no systematic summary of quality indicators applicable for osteoarthritis care in primary care settings.Entities:
Mesh:
Year: 2018 PMID: 28973146 PMCID: PMC5892173 DOI: 10.1093/fampra/cmx090
Source DB: PubMed Journal: Fam Pract ISSN: 0263-2136 Impact factor: 2.267
Figure 1.Flow diagram for selection of studies for the review.
Article characteristics
| First author/organization | Organization/initiative | Country/year | Study design |
|---|---|---|---|
| MacLean (15) | RAND/ACOVE | USA/2007 | Literature review for identifying candidate indicators; RAND/UCLA Appropriateness Method for critical appraisal of indicators |
| Pencharz (16) | Arthritis Foundation | USA/2004 | Literature review for identifying candidate indicators; consensus technique for critical appraisal of indicators |
| PCPI (17) | Physician Consortium for Performance Improvement/American Academy of Orthopaedic Surgeons | USA/2006 | Literature/clinical guidelines review for identifying candidate indicators; consensus technique for critical appraisal of indicators |
| EUMUSC.net (18) | The European Musculoskeletal Conditions Surveillance and Information Network project (EUMUSC.net project) | EU member states/2012 | Literature/clinical guidelines review for identifying candidate indicators; modified Delphi technique for critical appraisal of indicators by panellists from 9 European countries |
Appraisal of Indicators through Research and Evaluation Instrument Score
| First author | Appraisal of Indicators through Research and Evaluation Instrument-Standardized Score (%) | |||
|---|---|---|---|---|
| Purpose, relevance and organizational context | Stakeholder involvement | Scientific evidence | Additional evidence, formulation and usage | |
| MacLean (15) | 88 | 73 | 84 | 82 |
| Pencharz (16) | 78 | 67 | 84 | 67 |
| PCPI (17) | 86 | 94 | 78 | 87 |
| EUMUSCUS.net (18) | 86 | 76 | 84 | 85 |
Quality indicators for osteoarthritis care
| Indicator | Source(s) | Description and/or numerator, denominator of indicator | Scientific validity | Reliability |
|---|---|---|---|---|
| Structure indicators | ||||
| Access | EUMUSC.net, 2012 | Description: All professionals managing patients with osteoarthritis at a primary care setting should have continuous access to education on important preventive and therapeutic strategies in the management of osteoarthritis | High content and face validity | No reliability testing identified |
| Waiting time | EUMUSC.net, 2012 | Description: If a patient diagnosed with osteoarthritis has been referred to an orthopaedic surgeon, then the waiting time from first referral should not exceed 3 months | High content and face validity | No reliability testing identified |
| Process indicators | ||||
| Assessment | PCPI, 2006; MacLean, 2007; Pencharz, 2004 | Numerator: Number of patients from the denominator for whom a physical examination (visual inspection, palpation, range of motion) of the involved joint was performed during the initial visit | High content validity | Questionnaire-based test–retest aκ = 0.34, 63% exact agreement (21) |
| Denominator: Number of patients aged 18 years and older with a diagnosis of symptomatic osteoarthritis during the measurement period | ||||
| PCPI, 2006; MacLean, 2007; EUMUSC.net, 2012; Pencharz, 2004; NQF endorsed | Numerator: Number of patients from the denominator with a documentation of assessed pain annually and when new to a primary care provider | High content and face validity | No reliability testing identified | |
| Denominator: Number of patients aged 18 years and older with a diagnosis of symptomatic osteoarthritis during the measurement period | ||||
| PCPI, 2006; MacLean, 2007; EUMUSC.net, 2012; Pencharz, 2004; NQF endorsed | Numerator: Number of patients from the denominator with a documentation of assessed functional status annually and when new to a primary care provider | High content and face validity | Questionnaire-based test–retest κ = 0.53, 62% exact agreement (21) | |
| Denominator: Number of patients aged 18 years and older with a diagnosis of symptomatic osteoarthritis during the measurement period | ||||
| Education | EUMUSC.net, 2012; Pencharz, 2004 | Numerator: Number of patients from the denominator who have been given individually tailored education about the natural history, treatment and self- management of the disease at least once | High content and face validity | No reliability testing identified |
| Denominator: Number of patients aged 18 years and older with a diagnosis of osteoarthritis for >3 months during the measurement period | ||||
| Weight loss | Pencharz, 2004; MacLean, 2007 | Numerator: Number of patients from the denominator who have been advised annually to lose weight | High content validity | Questionnaire-based test–retest κ = 0.80, 90% exact agreement (21) |
| Denominator: Number of patients aged 18 years and older with a diagnosis of osteoarthritis who are overweight during the measurement period | ||||
| Pencharz, 2004; Darzi, 2008 | Numerator: Number of patients from the denominator who have been advised at least annually to lose weight and the benefit of weight loss on the symptoms of osteoarthritis have been explained | High content validity | No reliability testing identified | |
| Denominator: Number of patients aged 18 years and older with a diagnosis of symptomatic osteoarthritis who are overweight during the measurement period | ||||
| Pencharz, 2004; EUMUSC.net, 2012 | Numerator: Number of patients from the denominator who received referral to a weight loss programme | High content and face validity | Questionnaire-based test–retest κ = 0.80, 90% exact agreement (21) | |
| Denominator: Number of patients aged 18 years and older with a diagnosis of symptomatic osteoarthritis who are overweight for 3 years | ||||
| Therapeutic exercise | PCPI, 2006; EUMUSC.net, 2012; Pencharz, 2004; MacLean, 2007 | Numerator: Number of patients from the denominator who has no contraindication to exercise and are physically and mentally able to exercise was offered an individualized exercise programme or was referred to a relevant health professional | High content and face validity | Questionnaire-based test–retest κ = 0.34, 63% exact agreement (21) |
| Denominator: Number of patients aged 18 years and older with a diagnosis of symptomatic osteoarthritis for >3 months during the measurement period | ||||
| Assessment for use of anti-inflammatory medications | PCPI, 2006; NQF endorsed | Numerator: Number of patients from the denominator with a documentation of the assessment for use of anti-inflammatory or analgesic over-the-counter medications | High content and face validity | No reliability testing identified |
| Denominator: Number of patients aged 18 years and older with a diagnosis of osteoarthritis during the measurement period | ||||
| PCPI, 2006; MacLean, 2007; EUMUSC.net, 2012 | Numerator: Number of patients from the denominator taking a NSAID with a documented assessment for gastrointestinal and renal risk factors | High face validity | Questionnaire-based test–retest κ = 0.45, 64% exact agreement (21) | |
| Denominator: Number of patients aged 18 years and older with a diagnosis of osteoarthritis during the measurement period | ||||
| First-line pharmacological therapy | MacLean, 2007; Pencharz, 2004 | Numerator: Number of patients from the denominator who were prescribed acetaminophen first, unless there is a documented contraindication to use | High content validity | Questionnaire-based test–retest κ = 0.45, 68% exact agreement (21) |
| Denominator: Number of patients aged 18 years and older with a diagnosis of osteoarthritis who were started on pharmacological therapy, during the measurement period | ||||
| MacLean, 2007 | Numerator: Number of patients from the denominator who have been advised of the risk of liver toxicity | High content validity | No reliability testing identified | |
| Denominator: Number of patients aged 18 years and older with a diagnosis of osteoarthritis taking high-dose acetaminophen (>3 g/day), during the measurement period | ||||
| Pencharz, 2004 | Description: If oral pharmacologic therapy for osteoarthritis is changed from acetaminophen to a different oral agent, then there should be evidence that the patient has had a trial of maximum dose acetaminophen (suitable for age and comorbid conditions) | High content validity | No reliability testing identified | |
| Gastroprotection | PCPI, 2006; MacLean, 2007 | Numerator: Number of patients from the denominator taking a NSAID in combination with misoprostol or proton pump inhibitor | High content validity | Questionnaire-based test–retest κ = 0.45, 64% exact agreement (21) |
| Denominator: Number of patients aged 18 years and older with a diagnosis of osteoarthritis and a risk factor for gastrointestinal bleeding during the measurement period | ||||
| Assistive devices | MacLean, 2007; Pencharz, 2004; EUMUSC.net, 2012 | Numerator: Number of patients from the denominator for whom the need for ambulatory assistive devices has been assessed | High content and face validity | Questionnaire-based test–retest κ = 0.35, 68% exact agreement (21) |
| Denominator: Number of patients aged 18 years and older with a diagnosis of osteoarthritis who have reported difficulties of walking to accomplish activities of daily living during the measurement period | ||||
| Surgery | MacLean, 2007; Pencharz, 2004; EUMUSC.net, 2012; PCPI, 2006 | Numerator: Number of patients from the denominator who have been referred to an orthopaedic surgeon | High content and face validity | Questionnaire-based test–retest κ = 0.62, 76% exact agreement (21) |
| Denominator: Number of patients aged 18 years and older with a diagnosis of symptomatic osteoarthritis who failed to respond to pharmacological/non-pharmacological treatment during the measurement period | ||||
| Outcome indicators | ||||
| Functional improvement | EUMUSC.net, 2012 | Numerator: Number of patients from the denominator who have reported improvement of functional ability by 20% within 3 months after initiation/change of pharmacological/ non-pharmacological treatment | High content and face validity | No reliability testing identified |
| Denominator: Number of patients aged 18 years and older with a diagnosis of symptomatic osteoarthritis and functional limitation with initiation/change of pharmacological/non-pharmacological treatment during the measurement period | ||||
| Pain reduction | EUMUSC.net, 2012 | Numerator: Number of patients from the denominator who have reported reduction of pain level by 20% within 3 months after initiation/change of pharmacological/non-pharmacological treatment | High content and face validity | No reliability testing identified |
| Denominator: Number of patients aged 18 years and older with a diagnosis of symptomatic osteoarthritis initiation/change of pharmacological/non-pharmacological treatment during the measurement period | ||||
NSAID, Non-steroidal anti-inflammatory drug.
aκ = Cohen’s kappa coefficient.